< Back to all clusters
[HEALTH] · United States · 7 sources

started · updated

Radical Numerics administers AI-designed virus to human patient

In a medical milestone, the startup Radical Numerics has administered a cocktail of bacteriophages designed by artificial intelligence to a human patient suffering from a deadly bacterial infection. The treatment was conducted under a compassionate-use arrangement and was reportedly authorized by the FDA.

The viruses were created using the company’s Omnii-1 AI model, which is capable of designing viable bacteriophages to target specific bacterial strains. This approach aims to combat the global rise of antimicrobial resistance, a crisis where traditional antibiotics are increasingly ineffective. While the company has released a technical report, it has declined to disclose specific details regarding the patient or the medical team due to confidentiality requirements.

This development builds on previous research from the Arc Institute and Stanford University, where AI models like Evo 2 were used to generate thousands of viral genomes. The use of AI in phage therapy offers the potential for highly individualized treatments that can kill pathogens while sparing beneficial bacteria.

Entities

Chulalongkorn University · Eric Nguyen · FDA · Food and Drug Administration · Harvard University · Michael Baym · Omnii-1 · Radical Numerics · Roche

Claims

What the coverage asserts, and how many sources carry each claim.